81 related articles for article (PubMed ID: 12659951)
1. Interactions between verapamil and neutral and acidic liposomes: effects of the ionic strength.
Castaing M; Loiseau A; Mulliert G
Biochim Biophys Acta; 2003 Apr; 1611(1-2):107-14. PubMed ID: 12659951
[TBL] [Abstract][Full Text] [Related]
2. Designing multidrug-resistance modulators circumventing the reverse pH gradient in tumours.
Castaing M; Loiseau A; Dani M
J Pharm Pharmacol; 2001 Jul; 53(7):1021-8. PubMed ID: 11480537
[TBL] [Abstract][Full Text] [Related]
3. Thermal dependence of multidrug-resistant-modulator efficiency: a study in anionic liposomes.
Castaing M; Loiseau A; Dani M
J Pharm Pharmacol; 2000 Oct; 52(10):1171-8. PubMed ID: 11092560
[TBL] [Abstract][Full Text] [Related]
4. Membrane permeation by multidrug-resistance-modulators and non-modulators: effects of hydrophobicity and electric charge.
Castaing M; Brouant P; Loiseau A; Santelli-Rouvier C; Santelli M; Alibert-Franco S; Mahamoud A; Barbe J
J Pharm Pharmacol; 2000 Mar; 52(3):289-96. PubMed ID: 10757416
[TBL] [Abstract][Full Text] [Related]
5. Effects of cholesterol on dye leakage induced by multidrug-resistance modulators from anionic liposomes.
Castaing M; Loiseau A; Djoudi L
Eur J Pharm Sci; 2003 Jan; 18(1):81-8. PubMed ID: 12554076
[TBL] [Abstract][Full Text] [Related]
6. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance modulator interactions with neutral and anionic liposomes: membrane binding affinity and membrane perturbing activity.
Castaing M; Loiseau A; Mulliert G
J Pharm Pharmacol; 2005 May; 57(5):547-54. PubMed ID: 15901343
[TBL] [Abstract][Full Text] [Related]
8. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
[TBL] [Abstract][Full Text] [Related]
9. The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: implications for drug delivery.
Webb MS; Wheeler JJ; Bally MB; Mayer LD
Biochim Biophys Acta; 1995 Sep; 1238(2):147-55. PubMed ID: 7548129
[TBL] [Abstract][Full Text] [Related]
10. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
11. Synergy between verapamil and other multidrug -resistance modulators in model membranes.
Castaing M; Loiseau A; Cornish-Bowden A
J Biosci; 2007 Jun; 32(4):737-46. PubMed ID: 17762146
[TBL] [Abstract][Full Text] [Related]
12. Chalcogenopyrylium dyes as inhibitors/modulators of P-glycoprotein in multidrug-resistant cells.
Sawada GA; Raub TJ; William Higgins J; Brennan NK; Moore TM; Tombline G; Detty MR
Bioorg Med Chem; 2008 Nov; 16(22):9745-56. PubMed ID: 18849167
[TBL] [Abstract][Full Text] [Related]
13. Verapamil hydrochloride release characteristics from new copolymer zwitterionic matrix tablets.
Kostova B; Kamenska E; Ivanov I; Momekov G; Rachev D; Georgiev G
Pharm Dev Technol; 2008; 13(4):311-21. PubMed ID: 18649221
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug resistance-reverting agents.
Fusi F; Durante M; Spiga O; Trezza A; Frosini M; Floriddia E; Teodori E; Dei S; Saponara S
Naunyn Schmiedebergs Arch Pharmacol; 2016 Sep; 389(9):1033-43. PubMed ID: 27351883
[TBL] [Abstract][Full Text] [Related]
15. New co-polymer zwitterionic matrices for sustained release of verapamil hydrochloride.
Kostova B; Rachev D
Acta Pharm; 2007 Dec; 57(4):429-39. PubMed ID: 18165187
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity.
Tang J; Zhang L; Gao H; Liu Y; Zhang Q; Ran R; Zhang Z; He Q
Drug Deliv; 2016 May; 23(4):1130-43. PubMed ID: 25491241
[TBL] [Abstract][Full Text] [Related]
17. Ionic permeability of K, Na, and Cl in potassium-depolarized nerve. Dependency on pH, cooperative effects, and action of tetrodotoxin.
Strickholm A
Biophys J; 1981 Sep; 35(3):677-97. PubMed ID: 7272457
[TBL] [Abstract][Full Text] [Related]
18. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
[TBL] [Abstract][Full Text] [Related]
19. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
[TBL] [Abstract][Full Text] [Related]
20. Surface potential reflected in both gating and permeation mechanisms of sodium and calcium channels of the tunicate egg cell membrane.
Ohmori H; Yoshii M
J Physiol; 1977 May; 267(2):429-63. PubMed ID: 17734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
